Interestingly, one of the two chondrosarcoma patients that showed a partial response also exhibited the highest increase from baseline in both circulating caspase 3/7 and gDNA levels 24 h after dulanermin administration (Figure 3C). The gene discussed is CASP3; the disease is chondrosarcoma.